1,556
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes

, , , &
Article: 2305675 | Received 26 Oct 2023, Accepted 09 Jan 2024, Published online: 30 Jan 2024

References

  • Ananth CV, Duzyj CM, Yadava S, et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension. 2019;74(5):1–9. doi: 10.1161/hypertensionaha.119.12968.
  • Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1–134.e8. doi: 10.1016/j.ajog.2011.10.878.
  • ACOG Practice Bulletin No. 203. Chronic hypertension in pregnancy. Obstet Gynecol. 2019;133(1):e26–e50. doi: 10.1097/aog.0000000000003020.
  • Bello NA, Zhou H, Cheetham TC, et al. Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology/American Heart Association Blood Pressure guidelines and association with maternal and fetal outcomes. JAMA Netw Open. 2021;4(3):e213808. doi: 10.1001/jamanetworkopen.2021.3808.
  • Greenberg VR, Silasi M, Lundsberg LS, et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am J Obstet Gynecol. 2021;224(5):521.e1–521.e11. doi: 10.1016/j.ajog.2020.10.049.
  • Norton E, Shofer F, Schwartz H, et al. Adverse perinatal outcomes associated with stage 1 hypertension in pregnancy: a retrospective cohort study. Am J Perinatol. 2023;40(16):1781–1788. doi: 10.1055/s-0041-1739470.
  • Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348(7):g2301. doi: 10.1136/bmj.g2301.
  • Chappell LC, Enye S, Seed P, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002–1009. doi: 10.1161/hypertensionaha.107.107565.
  • Ankumah NE, Sibai BM. Chronic hypertension in pregnancy: diagnosis, management, and outcomes. Clin Obstet Gynecol. 2017;60(1):206–214. doi: 10.1097/grf.0000000000000255.
  • Roberts CL, Algert CS, Morris JM, et al. Hypertensive disorders in pregnancy: a population-based study. Med J Aust. 2005;182(7):332–335. doi: 10.5694/j.1326-5377.2005.tb06730.x.
  • Page EW, Christianson R. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. Am J Obstet Gynecol. 1976;126(7):821–833. doi: 10.1016/0002-9378(76)90671-2.
  • Hurrell A, Webster L, Chappell LC, et al. The assessment of blood pressure in pregnant women: pitfalls and novel approaches. Am J Obstet Gynecol. 2022;226(2s):S804–S818. doi: 10.1016/j.ajog.2020.10.026.
  • Kaimal AJ, Gandhi M, Pettker CM, et al. Clinical guidance for the integration of the findings of the chronic hypertension and pregnancy (CHAP) study. American College of Obstetricians and Gynecologists’ Committee on Clinical Practice Guidelines; 2022.
  • Bailey EJ, Tita ATN, Leach J, et al. Perinatal outcomes associated with management of stage 1 hypertension. Obstet Gynecol. 2023;142(6):1395–1404. doi: 10.1097/aog.0000000000005410.
  • Tita AT, Szychowski JM, Boggess K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386(19):1781–1792. doi: 10.1056/NEJMoa2201295.
  • Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339(10):667–671. doi: 10.1056/nejm199809033391004.
  • Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. doi: 10.1136/bmj.l2381.
  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799. doi: 10.1016/s0140-6736(05)17987-2.
  • Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2s):S786–S803. doi: 10.1016/j.ajog.2021.12.001.
  • Jung E, Romero R, Yeo L, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022;226(2s):S844–S866. doi: 10.1016/j.ajog.2021.11.1356.
  • Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022;226(2s):S1019–S1034. doi: 10.1016/j.ajog.2020.10.022.
  • Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–2869. doi: 10.1161/circulationaha.109.853127.
  • Burton GJ, Woods AW, Jauniaux E, et al. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–482. doi: 10.1016/j.placenta.2009.02.009.
  • Perni U, Sison C, Sharma V, et al. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension. 2012;59(3):740–746. doi: 10.1161/hypertensionaha.111.181735.
  • Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl. A):S32–S37. doi: 10.1016/j.placenta.2008.11.009.
  • ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. doi: 10.1097/aog.0000000000003018.
  • Tassi A, Sala A, Mazzera I, et al. Long-term outcomes of patients with preeclampsia: a review of the literature. Hypertens Pregnancy. 2023;42(1):2217448. doi: 10.1080/10641955.2023.2217448.
  • Srialluri N, Surapaneni A, Chang A, et al. Preeclampsia and long-term kidney outcomes: an observational cohort study. Am J Kidney Dis. 2023;82(6):698–705. doi: 10.1053/j.ajkd.2023.04.010.
  • Paquin A, Werlang A, Coutinho T. Arterial health after preeclampsia: role of chronic hypertension in the early vascular aging (EVA) study. Am J Hypertens. 2024;37(1):24–32. doi: 10.1093/ajh/hpad079.
  • Kivelä A, Heinonen S, Kivinen K, et al. Hypertensive pregnancy complications and maternal characteristics as predictors of cardiovascular health within ten years after delivery. Pregnancy Hypertens. 2023;34:5–12. doi: 10.1016/j.preghy.2023.09.001.
  • Aris IM, Kleinman KP, Belfort MB, et al. A 2017 US reference for singleton birth weight percentiles using obstetric estimates of gestation. Pediatrics. 2019;144(1):e20190076. doi: 10.1542/peds.2019-0076.
  • Committee Opinion No. 700: methods for estimating the due date. Obstet Gynecol. 2017;129(5):e150–e154. doi: 10.1097/aog.0000000000002046.
  • Becker DA, Machemehl HC, Biggio JR, et al. Pregnancy outcomes of exacerbated chronic hypertension compared with superimposed preeclampsia. Am J Perinatol. 2019;36(8):872–878. doi: 10.1055/s-0038-1675160.
  • Tuuli MG, Rampersad R, Stamilio D, et al. Perinatal outcomes in women with preeclampsia and superimposed preeclampsia: do they differ? Am J Obstet Gynecol. 2011;204(6):508.e1–508.e7. doi: 10.1016/j.ajog.2011.01.065.
  • Valent AM, DeFranco EA, Allison A, et al. Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks. Am J Obstet Gynecol. 2015;212(4):515.e1–515.e8. doi: 10.1016/j.ajog.2014.10.1090.
  • Giannubilo SR, Dell’Uomo B, Tranquilli AL. Perinatal outcomes, blood pressure patterns and risk assessment of superimposed preeclampsia in mild chronic hypertensive pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006;126(1):63–67. doi: 10.1016/j.ejogrb.2005.06.042.
  • Leonard SA, Formanowski BL, Phibbs CS, et al. Chronic hypertension in pregnancy and racial-ethnic disparities in complications. Obstet Gynecol. 2023;142(4):862–871. doi: 10.1097/aog.0000000000005342.
  • Kern-Goldberger AR, Friedman A, Moroz L, et al. Racial disparities in maternal critical care: are there racial differences in level of care? J Racial Ethn Health Disparities. 2022;9(2):679–683. doi: 10.1007/s40615-021-01000-z.
  • Goodin A, Delcher C, Valenzuela C, et al. The power and pitfalls of big data research in obstetrics and gynecology: a consumer’s guide. Obstet Gynecol Surv. 2017;72(11):669–682. doi: 10.1097/ogx.0000000000000504.
  • Sigakis MJ, Leffert LR, Mirzakhani H, et al. The validity of discharge billing codes reflecting severe maternal morbidity. Anesth Analg. 2016;123(3):731–738. doi: 10.1213/ane.0000000000001436.
  • Stanhope KK, Joseph NT, Platner M, et al. Validation of ICD-10 codes for gestational and pregestational diabetes during pregnancy in a large, public hospital. Epidemiology. 2021;32(2):277–281. doi: 10.1097/ede.0000000000001311.
  • Labgold K, Stanhope KK, Joseph NT, et al. Validation of hypertensive disorders during pregnancy: ICD-10 codes in a high-burden southeastern United States hospital. Epidemiology. 2021;32(4):591–597. doi: 10.1097/ede.0000000000001343.
  • Ray JG, Abdulaziz KE, Berger H, et al. Aspirin use for preeclampsia prevention among women with prepregnancy diabetes, obesity, and hypertension. JAMA. 2022;327(4):388–390. doi: 10.1001/jama.2021.22749.
  • Phelps AJD, Holmgren C. Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention. Arch Gynecol Obstet. 2022;308(4):1279–1286. doi: 10.1007/s00404-022-06773-0.
  • Ragunanthan NW, Lamb J, Hauspurg A, et al. Assessment of racial disparities in aspirin prophylaxis for preeclampsia prevention. Am J Perinatol. 2022. doi: 10.1055/s-0042-1743142.
  • Ayyash M, Goyert G, Pitts D, et al. Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia. Pregnancy Hypertens. 2023;34:1–4. doi: 10.1016/j.preghy.2023.09.002.
  • Butwick AJ, Druzin ML, Shaw GM, et al. Evaluation of US state-level variation in hypertensive disorders of pregnancy. JAMA Netw Open. 2020;3(10):e2018741. doi: 10.1001/jamanetworkopen.2020.18741.